AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇳🇬

Cefixime; Clavulanic Acid (Clavulanate Potassium) in Nigeria

11 products registered with NAFDAC 11 active

Brand / ProductReg. No.HolderStatusExpires
Atrimax 325 mg Tablets_
Tablet
A4-101747Evans Therapeutics Limitedactive25 Nov 2030
Podaxef 162.5 Dispersible Tablets
Dispersible tablet
A4-100663Marcson Healthcare Limitedactive20 Dec 2028
Cefexiclav 325 Tablets
Tablet
B4-6581SJS Life Sciences Limitedactive5 Jul 2028
Cefexiclav Powder for Oral Suspension 50 mg/31.25 mg/5 mL
Suspension
B4-6583SJS Life Sciences Limitedactive5 Jul 2028
Afrixime CLV 325 Tablets
Tablet
B4-4802Chanrai HealthCare Limitedactive1 Dec 2026
Bactacef 325 Tablets**
Tablet
C4-1898Synermed Nig Ltdactive27 Oct 2026
Chemityll 325 Tablets**
Tablet
C4-1745Chez Resources Pharmaceutical Limitedactive23 Jun 2026
Cfxclav 325 Tablet (check pack size)
Tablet
B4-6026Aquatix Pharmaceuticals Limitedactive6 May 2026
Marcfix Powder for Oral Suspension**
Powder for suspension
B4-3825Marcson Healthcare Limitedactive24 Feb 2026
Marcfix 325 Tablets**
Tablet
B4-2215Marcson Healthcare Limitedactive24 Feb 2026
Gramocef-CV Tablets**
Tablet
A4-9069Micro Nova Pharmaceuticals Ind Ltdactive24 Feb 2026

Cefixime; Clavulanic Acid (Clavulanate Potassium)NAFDAC Registration Details

NAFDAC (Nigeria) has 11 registered products containing Cefixime; Clavulanic Acid (Clavulanate Potassium), of which 11 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.

Track Cefixime; Clavulanic Acid (Clavulanate Potassium) registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.